Karuna Therapeutics Current Cash

Karuna Therapeutics (KRTX) currently reports a current cash of $190M as of December 2023. That compares with $1.1B in the prior-year period — down 83.5% year over year. Use the charts on this page to explore Karuna Therapeutics's current cash history and peer comparisons.

Karuna Therapeutics's current cash decreased from $1.1B to $190M — a 83.5% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Karuna Therapeutics reported $190M in current cash as of December 2023. That compares with $1.1B in the prior-year period — down 83.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $190M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Karuna Therapeutics, and consider following KRTX for alerts when major investors trade the stock.

Karuna Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $190M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KRTX with unrelated industries.